Arka Bagchi
arkabagchi.bsky.social
Arka Bagchi
@arkabagchi.bsky.social
L/S Equity, short focused. Scrutinizing low quality companies that are potentially misleading shareholders.
Reviva Pharmaceuticals (Ticker: RVPH) has absurd indications for their pipeline. Using an atypical antipsychotic for pulmonary hypertension? Is this a joke?
October 23, 2023 at 3:17 PM
The lunatic millionaire Cassava Sciences shareholder who is aggressively defending Wang is losing his mind over the CUNY report and suggesting it was systemic IT failure and committee member bias that threw Wang under the bus. Never mind Wang's inability to produce an iota of an original datum.
October 23, 2023 at 3:09 PM
Yes they've figured out a way to blame Dr. Bik. The Cassava shareholder-cult is going w the narrative that CUNY Investigative Committee member Orie Shafer's admiration for Dr. Bik is biasing the investigations into Wang's research misconduct. I'm confident Cassava themselves go with this narrative.
October 17, 2023 at 6:40 PM
Cassava Sciences (SAVA) dominoes begin to fall again. Leaked CUNY reports suggest CUNY Committee Responsible for investigating SAVA research misconduct is pissed off at Dr. Wang / SAVA AND the EiC's of these journals that allowed Wang/SAVA to get away with their nonsense.
October 13, 2023 at 2:03 AM
www.reddit.com/r/AuvelityMe...

Here is someone on Reddit saying they physically feel the effects from the first dose when switching from Bupropion aka Wellbutrin to AXSM's Auvelity (DM + Bupropion). Sweetheart, that is not how antidepressants work. That is how getting high on DM cough syrup works.
October 12, 2023 at 3:59 PM